Page last updated: 2024-10-30

mebendazole and Cholangitis

mebendazole has been researched along with Cholangitis in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Cholangitis: Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.

Research Excerpts

ExcerptRelevanceReference
" In the further course under pharmacotherapy with mebendazole without detection of cysts in the liver and in regression of the serological parameters, there was a recurrence after half a year with suppurative obstructive cholangitis and biliary pancreatitis."3.67[Echinococcosis of the bile ducts as an unusual cause of obstructive jaundice]. ( Bartscher, U; Brannath, J, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brannath, J1
Bartscher, U1

Other Studies

1 other study available for mebendazole and Cholangitis

ArticleYear
[Echinococcosis of the bile ducts as an unusual cause of obstructive jaundice].
    Deutsche medizinische Wochenschrift (1946), 1987, Jan-02, Volume: 112, Issue:1

    Topics: Adult; Ampulla of Vater; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis;

1987